Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study

A live attenuated zoster vaccine was licensed in the United States in 2006 for prevention of shingles in persons aged 60 years or older; the indication was extended in 2011 to cover those aged 50–59 years. We assessed vaccine effectiveness (VE) against shingles for 8 years after immunization at Kais...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Roger, Bartlett, Joan, Fireman, Bruce, Marks, Morgan, Hansen, John, Lewis, Edwin, Aukes, Laurie, Chen, Yong, Klein, Nicola P, Saddier, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Practice of Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018833/
https://www.ncbi.nlm.nih.gov/pubmed/29309521
http://dx.doi.org/10.1093/aje/kwx245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018833/
https://www.ncbi.nlm.nih.gov/pubmed/29309521
http://dx.doi.org/10.1093/aje/kwx245

Ejemplares similares